Victor Shifrin
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2018First federal award
$6.8MFederal grants as PI10 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
10 awards · $6.8M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Mar 13, 2025 | NIH | SBIR Phase II Development of a novel anti-neuroinflammatory experimental therapeutic for epilepsy and Alzheimer's risk | $50K | IMMUNOCHEM THERAPEUTICS LLC |
| Dec 6, 2024 | NIH | SBIR Phase II Development of a novel anti-neuroinflammatory experimental therapeutic for epilepsy and Alzheimer's risk | $1.2M | IMMUNOCHEM THERAPEUTICS LLC |
| Dec 8, 2023 | NIH | SBIR Phase II Development of a novel anti-neuroinflammatory experimental therapeutic for epilepsy and Alzheimer's risk | $1.2M | IMMUNOCHEM THERAPEUTICS LLC |
| Sep 18, 2022 | NIH | SBIR Phase I Novel anti-neuroinflammatory drug for aneurysmal subarachnoidhemorrhage (aSAH) | $498K | IMMUNOCHEM THERAPEUTICS LLC |
| Sep 18, 2022 | NIH | SBIR Phase II Novel anti-neuroinflammatory drug for aneurysmal subarachnoid hemorrhage (aSAH) | $498K | IMMUNOCHEM THERAPEUTICS LLC |
| Jul 28, 2022 | NIH | SBIR Phase II Mitigation of Radiation Therapy Induced Neuroinflammation and Cognitive Dysfunction | $722K | IMMUNOCHEM THERAPEUTICS LLC |
| Sep 1, 2021 | NIH | SBIR Phase I Development of a novel anti-neuroinflammatory experimental therapeutic forepilepsy and Alzheimer's risk | $450K | IMMUNOCHEM THERAPEUTICS LLC |
| Aug 31, 2021 | NIH | SBIR Phase II Development of a novel anti-neuroinflammatory experimental therapeutic for epilepsy and Alzheimer's risk | $450K | IMMUNOCHEM THERAPEUTICS LLC |
| Sep 14, 2019 | NIH | SBIR Phase II First-in-human study of MW151, a novel drug targeting neuroinflammation | $1.2M | IMMUNOCHEM THERAPEUTICS LLC |
| Sep 18, 2018 | NIH | SBIR Phase II First-in-human study of MW151, a novel drug targeting neuroinflammation | $499K | IMMUNOCHEM THERAPEUTICS LLC |
Peer ranks
Federal funding#148
Awards as PI#128
Patents#273
Companies
- IMMUNOCHEM THERAPEUTICS LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.